SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-080648
Filing Date
2020-07-02
Accepted
2020-07-02 16:54:51
Documents
4
Period of Report
2020-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2023976d1_8k.htm 8-K 31821
2 EXHIBIT 10.1 tm2023976d1_ex10-1.htm EX-10.1 413266
3 EXHIBIT 99.1 tm2023976d1_ex99-1.htm EX-99.1 10554
4 EXHIBIT 99.2 tm2023976d1_ex99-2.htm EX-99.2 171405
  Complete submission text file 0001104659-20-080648.txt   628396
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 201010397
SIC: 2834 Pharmaceutical Preparations